ASN's new Kidney Care First Model Calculator available for nephrologists

ASN's new Kidney Care First Model Calculator available for nephrologists

Cardiovascular diseases associated with increased risk of developing kidney failure Using the calculator, nephrologists can compare their practice's current Monthly Capitated Payment (MCP) to an Adjusted MCP (AMCP), which will be used in place of the regular MCP in the KCF option. The calculator also offers three options to help users compare their current reimbursement for CKD 4 and 5 patients to a Quarterly Capitated Payment (QCP) that will be used in the model to encourage more kidney care earlier in the progression of kidney diseases, before a person reaches kidney failure. "The calculator is meant to be a guide, but it cannot factor in every variable that might affect a nephrology practice," said David L. White, ASN Regulatory and Quality Officer. "We wanted to give nephrologists a tool that could shed some light on how their practice might fare in the program. ASN welcomes the government's focus on kidney care and its efforts to improve the lives of people with kidney diseases." The calculator also allows a practice to make assumptions about how it will perform in the Quality Metrics portion of the program. The calculator does not address the Comprehensive Kidney Care Contracting (CKCC) options in the KCC model. Applications to participate in the KCF Option close on Wednesday, January 22, 2020. The calculator is available at:



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More